Regeneron Pharmaceuticals, Inc.
MX ˙ BMV ˙ US75886F1075
SecurityMX:REGN / Regeneron Pharmaceuticals, Inc.
InstitutionExencial Wealth Advisors, Llc
Latest Disclosed Ownership436 shares
Latest Disclosed Value $ 337,173
Exencial Wealth Advisors, Llc reports 1.16% increase in ownership of REGN / Regeneron Pharmaceuticals, Inc.

On April 27, 2026 - Exencial Wealth Advisors, Llc filed a 13F-HR form disclosing ownership of 436 shares of Regeneron Pharmaceuticals, Inc. (MX:REGN) valued at $337,173 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 30, 2026 disclosing 431 shares of Regeneron Pharmaceuticals, Inc.. This represents a change in shares of 1.16% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-27 2026-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 436 5 1.16 337 1.51 0.0097
2026-01-30 2025-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 431 431 333 0.0105
2021-02-11 2020-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 0 -831 -100.00 0 -100.00
2020-11-13 2020-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 831 510 158.88 465 132.50 0.0247
2020-08-17 2020-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 321 321 200 0.0173
2020-05-15 2020-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 0 -905 -100.00 0 -100.00
2020-02-14 2019-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 905 0 0.00 340 35.46 0.0589
2019-11-13 2019-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 905 0 0.00 251 -11.31 0.0540
2019-08-14 2019-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 905 0 0.00 283 -23.92 0.0660
2019-05-08 2019-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 905 0 0.00 372 10.06 0.0883
2019-02-06 2018-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 905 315 53.39 338 42.02 0.0907
2018-11-02 2018-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 590 0 0.00 238 16.67 0.0554
2018-07-31 2018-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 590 0 0.00 204 0.49 0.0568
2018-05-08 2018-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 590 0 0.00 203 -8.56 0.0604
2018-02-09 2017-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 590 0 0.00 222 -15.91 0.0669
2017-11-08 2017-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 590 0 0.00 264 -8.97 0.0870
2017-08-10 2017-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 590 0 0.00 290 32.42 0.1187
2017-04-26 2017-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 590 0 0.00 219 0.92 0.0950
2017-01-20 2016-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 590 0 0.00 217 6.37 0.0919
2016-11-14 2016-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 590 -25 -4.07 204 -5.12 0.0903
2016-08-15 2016-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 615 -5 -0.81 215 -3.59 0.0969
2016-04-19 2016-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 620 135 27.84 223 -4.29 0.1050
2016-02-16 2015-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 485 5 1.04 233 4.48 0.1158
2015-11-06 2015-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 480 480 223 0.1090
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.